PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Diabetes Journal10.4093/kdj.2008.32.6.5322008326532The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus (Korean Diabetes Journal 32(5):445-452, 2008)Dong-Lim Kimhttps://synapse.koreamed.org/DOIx.php?id=10.4093/kdj.2008.32.6.532, https://synapse.koreamed.org/pdf/10.4093/kdj.2008.32.6.532, https://e-dmj.org/DOIx.php?id=10.4093/kdj.2008.32.6.532
Korean Diabetes Journal10.4093/kdj.2008.32.5.4452008325445The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes MellitusTae Seo Sohn, Jee In Lee, In Ju Kim, Kyung Wan Min, Hyun Shik Sonhttps://synapse.koreamed.org/DOIx.php?id=10.4093/kdj.2008.32.5.445, https://synapse.koreamed.org/pdf/10.4093/kdj.2008.32.5.445, https://e-dmj.org/DOIx.php?id=10.4093/kdj.2008.32.5.445
Diabetes, Obesity and Metabolism10.1111/j.1463-1326.2007.00722.x2008105436-437Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetesA. Garberhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1463-1326.2007.00722.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2007.00722.x/fullpdf
Diabetes, Obesity and Metabolism10.1111/j.1463-1326.2007.00721.x200796914-914Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetesH. Pokharna, B. Kannahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1463-1326.2007.00721.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2007.00721.x/fullpdf
Diabetes, Obesity and Metabolism10.1111/j.1463-1326.2006.00659.x200686650-660Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetesJ. Rosenstock, J. Rood, A. Cobitz, N. Biswas, H. Chou, A. Garberhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1463-1326.2006.00659.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2006.00659.x/fullpdf
10.21203/rs.3.rs-107043/v12020Evaluation of PRKAA2 Genetic Variation on Metformin Efficacy as an Initial Therapy Among Drug-Naïve Patients With Type II Diabetes MellitusDita Virginia, Mae Wahyuningsih, Dwi Nugrahaningsihhttps://www.researchsquare.com/article/rs-107043/v1, https://www.researchsquare.com/article/rs-107043/v1.html
International Journal of Diabetes Mellitus10.1016/j.ijdm.2009.03.0012009112-6Adding rosiglitazone to metformin in patients with type 2 diabetes: Effect on diabetes control and metabolic parametersHussein Raef, Abdulraof Al-Mahfouz, Abdullah Al-Khonaizanhttps://api.elsevier.com/content/article/PII:S1877593409000022?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1877593409000022?httpAccept=text/plain
Diabetes mellitus10.14341/2072-0351-5708200912468-71Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MBAlexander Sergeevich Ametov, Lyudmila Nikolaevna Bogdanovahttps://dia-endojournals.ru/dia/article/viewFile/5708/3486, https://dia-endojournals.ru/dia/article/viewFile/5708/3486
Yearbook of Medicine10.1016/s0084-3873(08)70284-020072007468-471Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patientsJ.L. Leahyhttps://api.elsevier.com/content/article/PII:S0084387308702840?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084387308702840?httpAccept=text/plain
Yearbook of Endocrinology10.1016/s0084-3741(08)70037-42007200766-69Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patientsJ.L. Leahyhttps://api.elsevier.com/content/article/PII:S0084374108700374?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084374108700374?httpAccept=text/plain